This Summit is designed to focus exclusively on thoracic surgical oncology with an emphasis on advanced surgical procedures, multidisciplinary care, clinical trials, and diagnostics, and cutting-edge technologies that are needed to improve care for patients with cancers of the lung, esophagus, mediastinum, and pleura. Educational content will be delivered by an international panel of experts via oral presentations from peer-reviewed abstract submissions, invited lecturers, debates, multiple high-quality “how I do it” videos, and special hands-on sessions where applicants can directly interact with faculty to learn new techniques and approaches.
ACCME Accreditation Statement
The American Association for Thoracic Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Association for Thoracic Surgery designates this live activity for a maximum of 11 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Financial Relationships
The planners and faculty for this activity do not have any relevant relationships with ACCME-defined ineligible companies to disclose. All relevant relationships have been mitigated according to ACCME Standards for Integrity and Independence in Accredited Continuing Education.
Disclosure of Commercial Support
The American Association for Thoracic Surgery received commercial support from the following organizations:
Bristol Myers Squibb
Johnson & Johnson Medical
Desired Learning Outcomes
At the end of this activity, participants will be able to:
Identify the latest minimally invasive surgical and diagnostic techniques;
- Expand their knowledge on molecular oncology in thoracic surgical oncology;
- Translate expanded knowledge into practice for the improvement of patient outcomes.